Journal of Gastroenterology

, Volume 42, Issue 7, pp 513–521 | Cite as

The epidemiology of hepatitis C infection in the United States

  • Vinod K. Rustgi



The prevalence of hepatitis C virus (HCV) infection in the United States has remained constant from 1988 through 2002, although the peak age of infection has increased. While the number of new HCV cases is declining, the rates of HCV-associated morbidity and mortality are increasing. We reviewed the risk factors for HCV infection, the laboratory methods used to diagnose it, the dynamics of disease progression, and the natural history of HCV infection.


Medline searches were performed using the key word HCV, together with incidence, risk factors, demographics, diagnostic methods, disease progression, natural history, normal alanine aminotransferase (ALT), fibrosis, and hepatocellular carcinoma (HCC).


Three characteristics—abnormal serum ALT, history of injection drug use, and blood transfusion before 1992—identified 85% of HCV-positive individuals 20–59 years old. About 75%–85% of acutely infected individuals progress to chronic infection, with up to 20% developing liver cirrhosis over 20–25 years, putting them at increased risk for end-stage liver disease and/or HCC. HCV-associated cirrhosis is the leading cause of liver transplantation in the United States. Rates of infection are higher in non-Hispanic blacks than in non-Hispanic whites and Mexican Americans and higher in men than in women. In the United States, over 70% of HCV-infected individuals are infected with genotype 1.


HCV infection is more prevalent than human immunodeficiency virus or hepatitis B virus infection and is particularly common among certain demographic groups. Individual rates of fibrosis progression vary, but identification of host and viral characteristics associated with disease progression may reveal the mechanisms of HCV-associated hepatic fibrosis/cirrhosis.

Key words

HCV incidence risk factors demographics disease progression 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Szabó, E, Lotz, G, Páska, C, Kiss, A, Schaff, Z 2003Viral hepatitis: new data on hepatitis C infectionPathol Oncol Res921521PubMedGoogle Scholar
  2. 2.
    Alter, MJ, Kruszon-Moran, D, Nainan, OV, McQuillan, G, Gao, F, Moyer, L,  et al. 1999The prevalence of hepatitis C virus infection in the United States, 1988 through 1994N Engl J Med34155662PubMedCrossRefGoogle Scholar
  3. 3.
    Armstrong, GL, Wasley, A, Simard, EP, McQuillan, GM, Kuhnert, WL, Alter, MJ 2006The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Ann Intern Med14470514PubMedGoogle Scholar
  4. 4.
    Hammett, TM, Harmon, MP, Rhodes, W 2002The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997Am J Public Health92178994PubMedGoogle Scholar
  5. 5.
    Harrison PM, Beck AJ. Prisoners in 2004. Bureau of Justice Statistics Bulletin. Available at: Accessed 14 December 2005Google Scholar
  6. 6.
    U.S.Department of Justice. Corrections statistics. Available at: Accessed 14 December 2005Google Scholar
  7. 7.
    Weinbaum, C, Lyerla, R, Margolis, HS 2003Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and PreventionMMWR Recomm Rep52136PubMedGoogle Scholar
  8. 8.
    Solomon, L, Flynn, C, Muck, K, Vertefeuille, J 2004Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilitiesJ Urban Health812537PubMedGoogle Scholar
  9. 9.
    Gamache, G, Rosenheck, R, Tessler, R 2001The proportion of veterans among homeless men: a decade laterSoc Psychiatry Psychiatr Epidemiol364815PubMedCrossRefGoogle Scholar
  10. 10.
    Desai, RA, Rosenheck, RA, Agnello, V 2003Prevalence of hepatitis C virus infection in a sample of homeless veteransSoc Psychiatry Psychiatr Epidemiol38396401PubMedGoogle Scholar
  11. 11.
    Briggs, ME, Baker, C, Hall, R, Gaziano, JM, Gagnon, D, Bzowej, N,  et al. 2001Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical centerHepatology3412005PubMedCrossRefGoogle Scholar
  12. 12.
    Mishra, G, Sninsky, C, Roswell, R, Fitzwilliam, S, Hyams, KC 2003Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospitalDig Dis Sci4881520PubMedCrossRefGoogle Scholar
  13. 13.
    Sloan, KL, Straits-Tröster, KA, Dominitz, JA, Kivlahan, DR 2004Hepatitis C tested prevalence and comorbidities among veterans in the US NorthwestJ Clin Gastroenterol3827984PubMedCrossRefGoogle Scholar
  14. 14.
    Rakela, J, Vargas, HE 2002Hepatitis C: magnitude of the problemLiver Transpl8S3S6PubMedCrossRefGoogle Scholar
  15. 15.
    National Institutes of Health2002Management of hepatitis C: 2002NIH Consensus Statement19146Google Scholar
  16. 16.
    Strader, DB, Wright, T, Thomas, DL, Seeff, LB 2004American Association for the Study of Liver Diseases practice guideline: diagnosis, management, and treatment of hepatitis CHepatology39114771PubMedCrossRefGoogle Scholar
  17. 17.
    Hoofnagle, JH, Hepatitis, C 1997the clinical spectrum of diseaseHepatology2615S20SPubMedCrossRefGoogle Scholar
  18. 18.
    Pockros, PJ 2002Developments in the treatment of chronic hepatitis CExpert Opin Investig Drugs1151528PubMedCrossRefGoogle Scholar
  19. 19.
    Shiffman, M, Di Bisceglie, AM, Lindsay, KL, Morishima, C, Wright, EC, Everson, GT,  et al. 2004and the HALT-C Trial Group. Peginterferon alpha-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentGastroenterology126101523PubMedCrossRefGoogle Scholar
  20. 20.
    Centers for Disease Control. Disease burden from hepatitis A, B, and C in the United States. Available at: Accessed 10 February 2006Google Scholar
  21. 21.
    Alter, MJ 1997Epidemiology of hepatitis CHepatology2662S5SPubMedCrossRefGoogle Scholar
  22. 22.
    Wong, JB, McQuillan, GM, McHutchison, JG, Poynard, T 2000Estimating future hepatitis C morbidity, mortality, and costs in the United StatesAm J Public Health9015629PubMedCrossRefGoogle Scholar
  23. 23.
    Ryder, SD, Irving, WL, Jones, DA, Neal, KR, Underwood, J 2004C, on behalf of the Trent Hepatitis C Study Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy studyGut534515PubMedCrossRefGoogle Scholar
  24. 24.
    Kim, WR 2002The burden of hepatitis C in the United StatesHepatology36S30S34PubMedCrossRefGoogle Scholar
  25. 25.
    Benvegnü, L, Gios, M, Boccato, S, Alberti, A 2004Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complicationsGut537449PubMedCrossRefGoogle Scholar
  26. 26.
    Dal Molin, G, Tiribelli, C, Campello, C 2003A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infectionAnn Hepatol27683PubMedGoogle Scholar
  27. 27.
    Pawlotsky, J-M 2003Diagnostic testing in hepatitis C virus infection: viral kinetics and genomicsSemin Liver Dis23311PubMedGoogle Scholar
  28. 28.
    Pawlotsky, J-M, Lonjon, I, Hezode, C, Raynard, B, Darthuy, F, Remire, J,  et al. 1998What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?Hepatology2717002PubMedCrossRefGoogle Scholar
  29. 29.
    Alter, MJ, Kuhnert, WL, Finelli, L 2003Guidelines for laboratory testing and result reporting of antibody to hepatitis C virusMMWR Recomm Rep52116PubMedGoogle Scholar
  30. 30.
    Centers for Disease Control and Prevention1998Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic diseaseMMWR Recomm Rep47139Google Scholar
  31. 31.
    Bukh, J, Purcell, RH, Miller, RH 1993At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwideProc Natl Acad Sci USA9082348PubMedCrossRefGoogle Scholar
  32. 32.
    Simmonds, P, Holmes, EC, Cha, TA, Chan, SW, McOmish, F, Irvine, B,  et al. 1993Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 regionJ Gen Virol7423919PubMedCrossRefGoogle Scholar
  33. 33.
    Nainan, OV, Alter, MJ, Kruszon-Moran, D, Gao, FX, Xia, G, McQuillan, G,  et al. 2006Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United StatesGastroenterology13147884PubMedCrossRefGoogle Scholar
  34. 34.
    Blatt, LM, Mutchnick, MG, Tong, MJ, Klion, FM, Lebovics, E, Freilich, B,  et al. 2000Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United StatesJ Viral Hepat7196202PubMedCrossRefGoogle Scholar
  35. 35.
    Nguyen, MH, Keeffe, EB 2005Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6Clin Gastroenterol Hepatol3S97S101PubMedCrossRefGoogle Scholar
  36. 36.
    Legrand-Abravanel, F, Nicot, F, Boulestin, A, Sandres-Saune, K, Vinel, JP, Alric, L,  et al. 2005Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infectionJ Med Virol77669PubMedCrossRefGoogle Scholar
  37. 37.
    Soriano, V, Nunez, M, Sanchez-Conde, M, Barreiro, P, Garcia-Samaniego, J, Martin-Carbonero, L,  et al. 2005Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4Antivir Ther1016770PubMedGoogle Scholar
  38. 38.
    Simmonds, P 1999Viral heterogeneity of the hepatitis C virusJ Hepatol315460PubMedCrossRefGoogle Scholar
  39. 39.
    Smith, DB, Pathirana, S, Davidson, F, Lawlor, E, Power, J, Yap, PL,  et al. 1997The origin of hepatitis C virus genotypesJ Gen Virol783218PubMedGoogle Scholar
  40. 40.
    Pawlotsky, JM 2003Hepatitis C virus genetic variability: pathogenic and clinical implicationsClin Liver Dis74566PubMedCrossRefGoogle Scholar
  41. 41.
    Löve, A, Molnegren, V, Månsson, AS, Smáradóttir, A, Thorsteinsson, SB, Widell, A 2004Evolution of hepatitis C virus variants following blood transfusion from one infected donor to several recipients: a long-term follow-upJ Gen Virol8544150PubMedCrossRefGoogle Scholar
  42. 42.
    VA National Hepatitis C Program. Hepatitis C: military-related blood exposures, risk factors, VA care. Available at:, Accessed 13 November 2004Google Scholar
  43. 43.
    Adams, PC, Arthur, MJ, Boyer, TD, DeLeve, LD, Di Bisceglie, AM, Hall, M,  et al. 2004Screening in liver disease: report of an AASLD clinical workshopHepatology39120412PubMedCrossRefGoogle Scholar
  44. 44.
    Alter, MJ, Mast, EE, Moyer, LA, Margolis, HS 1998Hepatitis CInfect Dis Clin North Am121326PubMedCrossRefGoogle Scholar
  45. 45.
    National Digestive Diseases Information Clearinghouse (NDDIC). Chronic hepatitis C: current disease management. Available at: Accessed 13 November 2004Google Scholar
  46. 46.
    Hoofnagle, JH 2002Course and outcome of hepatitis CHepatology36S21S29PubMedCrossRefGoogle Scholar
  47. 47.
    Poynard, T Bedossa, P Opolon, P for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups1997Natural history of liver fibrosis progression in patients with chronic hepatitis CLancet34982532PubMedCrossRefGoogle Scholar
  48. 48.
    Davis, GL, Albright, JE, Cook, SF, Rosenberg, DM 2003Projecting future complications of chronic hepatitis C in the United StatesLiver Transpl93318PubMedCrossRefGoogle Scholar
  49. 49.
    Wiley, TE, Brown, J, Chan, J 2002Hepatitis C infection in African Americans: its natural history and histological progressionAm J Gastroenterol977006PubMedCrossRefGoogle Scholar
  50. 50.
    FleckensteIn, J 2004Chronic hepatitis C in African Americans and other minority groupsCurr Gastroenterol Rep66670PubMedCrossRefGoogle Scholar
  51. 51.
    Reddy, KR, Hoofnagle, JH, Tong, MJ, Lee, WM, Pockros, P, Heathcote, EJ,  et al. 1999Racial differences in responses to therapy with interferon in chronic hepatitis C. The Consensus Interferon Study GroupHepatology3078793PubMedCrossRefGoogle Scholar
  52. 52.
    El-Serag, HB, Mason, AC 1999Rising incidence of hepatocellular carcinoma in the United StatesN Engl J Med34074550PubMedCrossRefGoogle Scholar
  53. 53.
    McHutchison, JG, Poynard, T, Pianko, S, Gordon, SC, Reid, AE, Dienstag, J,  et al. 2000The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy GroupGastroenterology119131723PubMedCrossRefGoogle Scholar
  54. 54.
    Jeffers, LJ, Cassidy, W, Howell, CD, Hu, S, Reddy, KR 2004Peginterferon alpha-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1Hepatology3917028PubMedCrossRefGoogle Scholar
  55. 55.
    Muir, AJ, Bornstein, JD, Killenberg, PG, the, for 2004Atlantic Coast Hepatitis Treatment Group. Peginterferon alpha-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whitesN Engl J Med350226571PubMedCrossRefGoogle Scholar
  56. 56.
    Tanaka, Y, Hanada, K, Mizokami, M, Yeo, AE, Shih, JW, Gojobori, T,  et al. 2002Inaugural Article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decadesProc Natl Acad Sci USA99155849PubMedCrossRefGoogle Scholar
  57. 57.
    El-Serag, HB, Mason, AC 2000Risk factors for the rising rates of primary liver cancer in the United StatesArch Intern Med160322730PubMedCrossRefGoogle Scholar
  58. 58.
    Nair, S, Shiv, KK, Thuluvath, PJ 2002Mortality from hepatocellular and biliary cancers: changing epidemiological trendsAm J Gastroenterol9716771PubMedCrossRefGoogle Scholar
  59. 59.
    Poynard, T, Yuen, MF, Ratziu, V, Lai, CL 2003Viral hepatitis CLancet3622095100PubMedCrossRefGoogle Scholar
  60. 60.
    Monga, HK, Rodriguez-Barradas, MC, Breaux, K, Khattak, K, Troisi, CL, Velez, M,  et al. 2001Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infectionClin Infect Dis332407PubMedCrossRefGoogle Scholar
  61. 61.
    Bjoro, K, Froland, SS, Yun, Z, Samdal, HH, Haaland, T 1994Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulinN Engl J Med331160711PubMedCrossRefGoogle Scholar
  62. 62.
    Berenguer, M, Prieto, M, Palau, A, Rayon, JM, Carrasco, D, Juan, FS,  et al. 2003Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosisLiver Transpl922835PubMedCrossRefGoogle Scholar
  63. 63.
    Arenas, JI, Gallegos-Orozco, JF, Laskus, T, Wilkinson, J, Khatib, A, Fasola, C,  et al. 2004Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantationJ Infect Dis189203746PubMedCrossRefGoogle Scholar
  64. 64.
    Guido, M, Bortolotti, F, Leandro, G, Jara, P, Hierro, L, Larrauri, J,  et al. 2003Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?Am J Gastroenterol986603PubMedCrossRefGoogle Scholar
  65. 65.
    Vogt, M, Lang, T, Frosner, G, Klingler, C, Sendl, AF, Zeller, A,  et al. 1999Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screeningN Engl J Med34186670PubMedCrossRefGoogle Scholar
  66. 66.
    Vogt, M, Mühlbauer, F, Braun, SL, Lang, T, Busch, R, Lange, R,  et al. 2004Prevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screeningInfection321347PubMedCrossRefGoogle Scholar
  67. 67.
    Tagariello, G, Gerotto, M, Pontisso, P, Belvini, D, Salviato, R, Radossi, P,  et al. 2004Hepatitis C virus quasispecies in the natural course of HCV-related disease in patients with haemophiliaHaemophilia10816PubMedCrossRefGoogle Scholar
  68. 68.
    Okuda, K, Yokosuka, O 2004Natural history of chronic hepatitis C in patients on hemodialysis: case control study with 4–23 years of follow-upWorld J Gastroenterol10220912PubMedGoogle Scholar
  69. 69.
    Kenny-Walsh, E, the, for 1999Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulinN Engl J Med340122833PubMedCrossRefGoogle Scholar
  70. 70.
    Harris, HE, Ramsay, ME, Andrews, N, Eldridge, KP 2002Clinical course of hepatitis C virus during the first decade of infection: cohort studyBMJ3244503PubMedCrossRefGoogle Scholar
  71. 71.
    Minola, E, Prati, D, Suter, F, Maggiolo, F, Caprioli, F, Sonzogni, A,  et al. 2002Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis CBlood99458891PubMedCrossRefGoogle Scholar
  72. 72.
    Ramalho, F, Costa, A, Pires, A, Cabrita, P, Serejo, F, Correia, AP,  et al. 2000Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis CDig Dis Sci451827PubMedCrossRefGoogle Scholar
  73. 73.
    Rubbia-Brandt, L, Fabris, P, Paganin, S, Leandro, G, Male, PJ, Giostra, E,  et al. 2004Steatosis affects chronic hepatitis C progression in a genotype specific wayGut5340612PubMedCrossRefGoogle Scholar
  74. 74.
    Mihm, S, Fayyazi, A, Hartmann, H, Ramadori, G 1997Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotypeHepatology257359PubMedCrossRefGoogle Scholar
  75. 75.
    Duffy, M, Salemi, M, Sheehy, N, Vandamme, AM, Hegarty, J, Curry, M,  et al. 2002Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infectionVirology30135464PubMedCrossRefGoogle Scholar
  76. 76.
    Gaud, U, Langer, B, Petropoulou, T, Thomas, HC, Karayiannis, P 2003Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defectsJ Med Virol693506PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2007

Authors and Affiliations

  • Vinod K. Rustgi
    • 1
  1. 1.Transplant InstituteGeorgetown University Medical CenterFairfaxUSA

Personalised recommendations